High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue 5, 2008, Pages 961-967

  Molina, Auxiliadora ^a   Del Campo, Rosa ^a   Máiz, Luis ^a   Morosini, María Isabel ^a   Lamas, Adelaida ^a   Baquero, Fernando ^a   Cantón, Rafael ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Biofilms; MLST; MRSA; Mutation frequency; PFGE

Indexed keywords

AMIKACIN; AZITHROMYCIN; BACTERIAL PROTEIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; ERYTHROMYCIN; FOSFOMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; MACROLIDE; METICILLIN; PROTEIN PVL; RIFAMPICIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIUM CULTURE; BACTERIUM ISOLATE; BIOFILM; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR CLONING; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BIOFILMS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; CYSTIC FIBROSIS; DNA FINGERPRINTING; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; FEMALE; HUMANS; MALE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 54549100478     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn302     Document Type: Article

References (37)

1. Renders N, Van Belkum A, Overbeek SE et al. Molecular epidemiology of Staphylococcus aureus strains colonizing the lungs of related and unrelated cystic fibrosis patients. Clin Microbiol Infect 1997; 3: 216-21.
2. Campana S, Taccetti G, Ravenni N et al. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center. J Cyst Fibros 2004; 3: 159-63.
3. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry: Annual Data Report 2005. Bethesda, MD, 2006.
4. Ren CL, Morgan WJ, Konstan MW et al. Presence of methicillin-resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function. Pediatr Pulmonol 2007; 42: 513-8.
5. Valenza G, Tappe D, Turnwald D et al. Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis. J Cyst Fibros 2008; 7: 123-7.
6. Vergison A, Denis O, Deplano A et al. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients. J Antimicrob Chemother 2007; 59: 893-9.
7. Nadesalingam K, Conway SP, Denton M. Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by patients with cystic fibrosis. J Cyst Fibros 2005; 4: 49-52.
8. Saiman L, Siegel J. Infection control in cystic fibrosis. Clin Microbiol Rev 2004; 17: 57-71.
9. Stone A, Saiman L. Update on the epidemiology and management of Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus, in patients with cystic fibrosis. Curr Opin Pulm Med 2007; 13: 515-21.
10. Goerke C, Kraning K, Stern M et al. Molecular epidemiology of community-acquired Staphylococcus aureus in families with and without cystic fibrosis patients. J Infect Dis 2000; 181: 984-9.
11. Kahl BC, Duebbers A, Lubritz G et al. Population dynamics of persistent Staphylococcus aureus isolated from the airways of cystic fibrosis patients during a 6-year prospective study. J Clin Microbiol 2003; 41: 4424-7.
12. Prunier AL, Malbruny B, Laurans M et al. High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains. J Infect Dis 2003; 187: 1709-16.
13. Caraher E, Reynolds G, Murphy P et al. Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro. Eur J Clin Microbiol Infect Dis 2007; 26: 213-6.
14. Di Bonaventura G, Prosseda G, Del Chierico F et al. Molecular characterization of virulence determinants of Stenotrophomonas maltophilia strains isolated from patients affected by cystic fibrosis. Int J Immunopathol Pharmacol 2007; 20: 529-37.
15. García-Castillo M, Morosini MI, Valverde A et al. Differences in biofilm development and antibiotic susceptibility among Streptococcus pneumoniae isolates from cystic fibrosis samples and blood cultures. J Antimicrob Chemother 2007; 59: 301-4.
16. Elizur A, Orscheln RC, Ferkol TW et al. Panton-Valentine Leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis. Chest 2007; 131: 1718-25.
17. Glikman D, Siegel JD, David MZ et al. Complex molecular epidemiology of methicillin-resistant Staphylococcus aureus isolates from children with cystic fibrosis in the era of epidemic community-associated methicillin-resistant S. aureus. Chest 2008; 133: 1381-7.
18. Wong K, Roberts MC, Owens L et al. Selective media for the quantitation of bacteria in cystic fibrosis sputum. J Med Microbiol 1984; 17: 113-9.
19. van Belkum A, Tassios PT, Dijkshoorn L et al. Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clin Microbiol Infect Dis 2007; 13: 1-46.
20. Enright MC, Day NP, Davies CE et al. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000; 38: 1008-15.
21. Yang JA, Park DW, Sohn JW et al. Novel PCR-restriction fragment length polymorphism analysis for rapid typing of staphylococcal cassette chromosome mec elements. J Clin Microbiol 2006; 44: 236-8.
22. Lina G, Piemont Y, Godail-Gamot F et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29 1128-32.
23. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Informational Supplement M100-S17. CLSI, Wayne, PA, USA, 2007.
24. Moskowitz SM, Foster JM, Emerson J et al. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol 2004; 42: 1915-22.
25. Oliver A, Cantón R, Campo P et al. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 2000; 288: 1251-4.
26. Thomas SR, Gyi KM, Gaya H et al. Methicillin-resistant Staphylococcus aureus: Impact at a national cystic fibrosis centre. J Hosp Infect 1998; 40: 203-9.
27. Tristan A, Bes M, Meugnier H et al. Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus. Emerg Infect Dis 2007; 13: 594-600.
28. Vindel A, Trincado P, Gomez E et al. Prevalence and evolution of methicillin-resistant Staphylococcus aureus in Spanish hospitals between 1996 and 2002. J Clin Microbiol 2006; 44: 266-70.
29. Layer F, Ghebremedhin B, Konig W et al. Heterogeneity of methicillin-susceptible Staphylococcus aureus strains at a German University Hospital implicates the circulating-strain pool as a potential source of emerging methicillin-resistant S. aureus clones. J Clin Microbiol 2006; 44: 2179-85.
30. Kerttula AM, Lyytikainen O, Karden-Lilja M et al. Nationwide trends in molecular epidemiology of methicillin-resistant Staphylococcus aureus, Finland, 1997-2004. BMC Infect Dis 2007; 7: 94.
31. Wisplinghoff H, Ewertz B, Wisplinghoff S et al. Molecular evolution of methicillin-resistant Staphylococcus aureus in the metropolitan area of Cologne, Germany, from 1984 to 1998. J Clin Microbiol 2005; 43: 5445-51.
32. Crisostomo MI, Westh H, Tomasz A et al. The evolution of methicillin resistance in Staphylococcus aureus: Similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones. Proc Natl Acad Sci USA 2001; 98: 9865-70.
33. Enright MC, Robinson DA, Randle G et al. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA 2002; 99: 7687-92.
34. Balkhy HH, Memish ZA, Almuneef MA et al. Methicillin-resistant Staphylococcus aureus: A 5-year review of surveillance data in a tertiary care hospital in Saudi Arabia. Infect Control Hosp Epidemiol 2007; 28: 976-82.
35. Petersdorf S, Oberdorfer K, Wendt C. Longitudinal study of the molecular epidemiology of methicillin-resistant Staphylococcus aureus at a university hospital. J Clin Microbiol 2006; 44: 4297-302.
36. Manago K, Nishi J, Wakimoto N et al. Biofilm formation by and accessory gene regulator typing of methicillin-resistant Staphylococcus aureus strains recovered from patients with nosocomial infections. Infect Control Hosp Epidemiol 2006; 27: 188-90.
37. -1- mice. Antimicrob Agents Chemother 2007; 51: 3677-87.